Anti-CD8 antibodies and uses thereof

Provided are anti-CD8 antibodies that bind human CD8 and do not stimulate or inhibit the activation of CD8+ T cells. Also provided are nucleic acids encoding such anti-CD8 antibodies, vectors comprising such nucleic acids, host cells comprising same, and methods of making such anti-CD8 antibodies. A...

Full description

Saved in:
Bibliographic Details
Main Authors ALBERT MATTHEW LAWRENCE, CHEN YVONNE M, WILLIAMS SIMON-PETER, CHIANG EUGENE YUUAN, GROGAN JANE LOUISE
Format Patent
LanguageChinese
English
Published 16.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided are anti-CD8 antibodies that bind human CD8 and do not stimulate or inhibit the activation of CD8+ T cells. Also provided are nucleic acids encoding such anti-CD8 antibodies, vectors comprising such nucleic acids, host cells comprising same, and methods of making such anti-CD8 antibodies. Also provided are anti-CD8 antibodies conjugated to a detectable label. Provided are methods of usingsuch anti-CD8 antibodies to detect CD8+ T cells in a subject, monitor disease progress in a subject having cancer, and monitor treatment progress in a subject having cancer. 提供的是结合人CD8且并不刺激或抑制CD8T细胞激活的抗CD8抗体。还提供的是编码此类抗CD8抗体的核酸,包含此类核酸的载体,包含其的宿主细胞,和生成此类抗CD8抗体的方法。还提供的是与可检测标记物缀合的抗CD8抗体。提供的是在受试者中使用此类抗CD8抗体来检测CD8T细胞,在具有癌症的受试者中监测疾病进展,和在具有癌症的受试者中监测治疗进展的方法。
AbstractList Provided are anti-CD8 antibodies that bind human CD8 and do not stimulate or inhibit the activation of CD8+ T cells. Also provided are nucleic acids encoding such anti-CD8 antibodies, vectors comprising such nucleic acids, host cells comprising same, and methods of making such anti-CD8 antibodies. Also provided are anti-CD8 antibodies conjugated to a detectable label. Provided are methods of usingsuch anti-CD8 antibodies to detect CD8+ T cells in a subject, monitor disease progress in a subject having cancer, and monitor treatment progress in a subject having cancer. 提供的是结合人CD8且并不刺激或抑制CD8T细胞激活的抗CD8抗体。还提供的是编码此类抗CD8抗体的核酸,包含此类核酸的载体,包含其的宿主细胞,和生成此类抗CD8抗体的方法。还提供的是与可检测标记物缀合的抗CD8抗体。提供的是在受试者中使用此类抗CD8抗体来检测CD8T细胞,在具有癌症的受试者中监测疾病进展,和在具有癌症的受试者中监测治疗进展的方法。
Author CHEN YVONNE M
WILLIAMS SIMON-PETER
ALBERT MATTHEW LAWRENCE
GROGAN JANE LOUISE
CHIANG EUGENE YUUAN
Author_xml – fullname: ALBERT MATTHEW LAWRENCE
– fullname: CHEN YVONNE M
– fullname: WILLIAMS SIMON-PETER
– fullname: CHIANG EUGENE YUUAN
– fullname: GROGAN JANE LOUISE
BookMark eNrjYmDJy89L5WRQccwrydR1drFQSAQykvJTMlOLgcwUhdJiIKMkI7UoNT-Nh4E1LTGnOJUXSnMzKLq5hjh76KYW5MenFhckJqfmpZbEO_sZGhoaWZoaW5o4GhOjBgCYtyfJ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 抗CD8抗体及其用途
ExternalDocumentID CN111295394A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN111295394A3
IEDL.DBID EVB
IngestDate Fri Aug 30 05:41:37 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN111295394A3
Notes Application Number: CN201880051235
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200616&DB=EPODOC&CC=CN&NR=111295394A
ParticipantIDs epo_espacenet_CN111295394A
PublicationCentury 2000
PublicationDate 20200616
PublicationDateYYYYMMDD 2020-06-16
PublicationDate_xml – month: 06
  year: 2020
  text: 20200616
  day: 16
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies HOFFMANN LA ROCHE
RelatedCompanies_xml – name: HOFFMANN LA ROCHE
Score 3.3996682
Snippet Provided are anti-CD8 antibodies that bind human CD8 and do not stimulate or inhibit the activation of CD8+ T cells. Also provided are nucleic acids encoding...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Title Anti-CD8 antibodies and uses thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200616&DB=EPODOC&locale=&CC=CN&NR=111295394A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFPVNp6LzBxVG34pLk4b1ociWtgxh3ZApexttmmJ9WIftEPzrvZTO-aJvRwKX5INL7pLvLgA9x01s6RJmqSyLLUaItGLlMIszIrlMGE1qEs0k4uMX9rRwFi143-bC1HVCP-viiGhREu29qvfr9e4Sy6-5leVDkmNT8RjOPd9somMdHxNu-iMvmE39qTCF8ERkRs8e0X6FQ1023IN97UbrOvvB60hnpax_HynhCRzMUNuqOoXW11sHjsT257UOHE6aB28UG9srz6A3XFW5JfyBgWDkSaHpfyimxqZEQftxqsjO4T4M5mJs4XDLn7UtRbSbGb2ANsb86hKMdEBjaXNEEkMYm1JXqTjjOg9VkX4q-1fQ_VtP97_OazjWOGm2E-E30K4-NuoWz9UquasB-QZU-3rO
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4gGvFNUYP4CxOyt0W6dZU9LAY6CCoMYqbhjWxdF_GBETdi4l_vtQHxRd8ubXJtL7nefe13LUDTcWNLuISaMk0jkxIizEg61GSUCCZiaseaRDMK2OCFPk6daQneN7Uw-p3QT_04InqUQH8v9H693B5i-Zpbmd_Gc2zK7vuh5xtrdKzwMWGG3_V6k7E_5gbnHg-M4NkjKq9wbJd2dmD3DiGhhkqvXVWVsvwdUvqHsDdBbYviCEpfb1Wo8M3Pa1XYH60vvFFc-15-DM3Oopib3G830BjzOFP0PxSTxipHQeVxMktP4KbfC_nAxOFmP2ub8WA7M_sUyoj5ZQ0aSduOhMXQkghhLNt2pYxSpupQJWklonUG9b_11P_rvIbKIBwNZ8OH4OkcDpTNFPOJsAsoFx8reYkxtoivtHG-ATfNfbg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Anti-CD8+antibodies+and+uses+thereof&rft.inventor=ALBERT+MATTHEW+LAWRENCE&rft.inventor=CHEN+YVONNE+M&rft.inventor=WILLIAMS+SIMON-PETER&rft.inventor=CHIANG+EUGENE+YUUAN&rft.inventor=GROGAN+JANE+LOUISE&rft.date=2020-06-16&rft.externalDBID=A&rft.externalDocID=CN111295394A